Vanda Pharmaceuticals
Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.
-
Custom gene-targeting drug tested in single patient with rare nerve disease
Disease control OngoingThis study tests a custom-made drug (VCA-894A) in one person with a specific genetic form of Charcot-Marie-Tooth disease (CMT2S). The drug is designed to fix a genetic error and restore a missing protein. It is given via spinal injection to see if it is safe and can improve muscl…
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New topical treatment shows promise for stubborn toenail fungus
Disease control OngoingThis study tests a new topical solution called VTR-297 for mild to severe toenail fungus. About 50 adults will apply the solution for 4 weeks. Researchers will check safety and whether the fungus clears using lab tests. The goal is to find a better treatment option for this commo…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New motion sickness pill could make travel easier for millions
Symptom relief OngoingThis study tests a drug called tradipitant in 705 adults aged 18-75 who often get motion sickness. The goal is to see if it safely reduces nausea and vomiting during travel. Participants take the drug before or during trips, and researchers monitor side effects and how well it wo…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC